Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients

被引：0
|
作者：
Hiroko Shindo
Shinya Maekawa
Kazuki Komase
Ryota Sueki
Mika Miura
Makoto Kadokura
Kuniaki Shindo
Fumitake Amemiya
Takatoshi Kitamura
Yasuhiro Nakayama
Taisuke Inoue
Minoru Sakamoto
Shun-ichi Okada
Yasuhiro Asahina
Namiki Izumi
Masao Honda
Shuichi Kaneko
Nobuyuki Enomoto
机构：
[1] University of Yamanashi,First Department of Internal Medicine
[2] Musashino Red Cross Hospital,Division of Gastroenterology and Hepatology
[3] Kanazawa University Graduate School of Medicine,Department of Gastroenterology
来源：
Hepatology International | 2012年 / 6卷
关键词：
HCV; Protease inhibitor; Naturally occurring viral resistance mutations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：482 / 490
页数：8
相关论文
共 50 条
  • [41] Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct-acting antiviral therapies
    Yoneyama, Hirohito
    Morishita, Asahiro
    Iwama, Hisakazu
    Fujita, Koji
    Masaki, Takahiro
    Tani, Joji
    Tadokoro, Tomoko
    Nomura, Takako
    Sakamoto, Teppei
    Oura, Kyoko
    Takuma, Kei
    Nakahara, Mai
    Mimura, Shima
    Deguchi, Akihiro
    Oryu, Makoto
    Tsutsui, Kunihiko
    Himoto, Takashi
    Shimotohno, Kunitada
    Wakita, Takaji
    Kobara, Hideki
    Masaki, Tsutomu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (04) : 1126 - 1135
  • [42] Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry
    Lin, Liang-Tzung
    Chung, Chueh-Yao
    Hsu, Wen-Chan
    Chang, Shun-Pang
    Hung, Ting-Chun
    Shields, Justin
    Russell, Rodney S.
    Lin, Chih-Chan
    Li, Chien-Feng
    Yen, Ming-Hong
    Tyrrell, D. Lorne J.
    Lin, Chun-Ching
    Richardson, Christopher D.
    JOURNAL OF HEPATOLOGY, 2015, 62 (03) : 541 - 548
  • [43] Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data
    Ishigami, Masatoshi
    Hayashi, Kazuhiko
    Honda, Takashi
    Kuzuya, Teiji
    Ishizu, Yoji
    Ishikawa, Tetsuya
    Nakano, Isao
    Urano, Fumihiro
    Kumada, Takashi
    Yoshioka, Kentaro
    Goto, Hidemi
    Hirooka, Yoshiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (11) : 1879 - 1886
  • [44] Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C
    Furusyo, Norihiro
    Ogawa, Eiichi
    Nakamuta, Makoto
    Kajiwara, Eiji
    Nomura, Hideyuki
    Dohmen, Kazufumi
    Takahashi, Kazuhiro
    Satoh, Takeaki
    Azuma, Koichi
    Kawano, Akira
    Tanabe, Yuichi
    Kotoh, Kazuhiro
    Shimoda, Shinji
    Hayashi, Jun
    JOURNAL OF HEPATOLOGY, 2013, 59 (02) : 205 - 212
  • [45] Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b
    Tsubota, Akihito
    Shimada, Noritomo
    Atsukawa, Masanori
    Abe, Hiroshi
    Kato, Keizo
    Ika, Makiko
    Matsudaira, Hiroshi
    Nagatsuma, Keisuke
    Matsuura, Tomokazu
    Aizawa, Yoshio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 144 - 150
  • [46] Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
    Liu, Chen-Hua
    Shih, Yu-Lueng
    Yang, Sheng-Shun
    Lin, Chih-Lin
    Fang, Yu-Jen
    Cheng, Pin-Nan
    Chen, Chi-Yi
    Peng, Cheng-Yuan
    Hsieh, Tsai-Yuan
    Chiu, Yen-Cheng
    Su, Tung-Hung
    Liu, Chun-Jen
    Yang, Hung-Chih
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (11) : 1977 - 1983
  • [47] Effectiveness and safety of daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: Systematic review and meta-analysis
    Wang, Hui-Lian
    Lu, Xi
    Yang, Xudong
    Xu, Nan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (01) : 45 - 52
  • [48] Comparison of Naturally Occurring Resistance-Associated Substitutions Between 2008 and 2016 in Chinese Patients with Chronic Hepatitis C Virus Infection
    Huang, Wei
    Wang, Mingjie
    Gong, Qiming
    Yu, Demin
    Chen, Peizhan
    Lin, Junyu
    Han, Yue
    Su, Yu
    Qu, Lihong
    Zhang, Xinxin
    MICROBIAL DRUG RESISTANCE, 2019, 25 (06) : 944 - 950
  • [49] Evolutionary characteristics and immune mutation of hepatitis C virus genotype 1b among intravenous drug users in mainland, China
    Wu, Sheng
    Yuan, Huangbo
    Fan, Hong
    Xu, Yiyun
    Liu, Zhenqiu
    Wu, Xuefu
    Wu, Mingshan
    Zhang, Xin
    Shi, Tingting
    Zhang, Tiejun
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (03) : 209 - 217
  • [50] Reconstruction of the evolutionary dynamics of the hepatitis C virus 1b epidemic in Turkey
    Ciccozzi, Massimo
    Ciccaglione, Anna-Rita
    Lo Presti, Alessandra
    Yalcinkaya, Tulay
    Taskan, Zeynep Pinar
    Equestre, Michele
    Costantino, Angela
    Bruni, Roberto
    Ebranati, Erica
    Salemi, Marco
    Gray, Rebecca
    Rezza, Giovanni
    Galli, Massimo
    Zehender, Gianguglielmo
    INFECTION GENETICS AND EVOLUTION, 2011, 11 (05) : 863 - 868
12345